Radiation boost after CAR-T: a new shot at fighting stubborn lymphoma
NCT ID NCT04473937
Summary
This small, early-stage study tested whether adding a short course of radiation therapy could help control lymphoma that did not fully respond to CAR-T cell therapy. The goal was to see if radiation could improve the body's immune response against the cancer and work together with the CAR-T cells. The study was terminated early after enrolling only 3 participants, so results are very limited.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.